Terms: = Breast cancer AND KEAP1, INrf2, ENSG00000079999, 9817, Q14145, MGC9454, MGC4407, MGC20887, MGC1114, MGC10630, KLHL19, KIAA0132 AND Treatment
29 results:
1. Interplay of oxidative stress, cellular communication and signaling pathways in cancer.
Iqbal MJ; Kabeer A; Abbas Z; Siddiqui HA; Calina D; Sharifi-Rad J; Cho WC
Cell Commun Signal; 2024 Jan; 22(1):7. PubMed ID: 38167159
[TBL] [Abstract] [Full Text] [Related]
2. Wogonin Diminishes Radioresistance of breast cancer via Inhibition of the Nrf2/HIF-1[Formula: see text] Pathway.
Wang T; Wang P; Wang S; Ma Y; Zhao Z; Long F
Am J Chin Med; 2023; 51(8):2243-2262. PubMed ID: 37903716
[TBL] [Abstract] [Full Text] [Related]
3. The novel β-TrCP protein isoform hidden in circular RNA confers trastuzumab resistance in HER2-positive breast cancer.
Wang S; Wang Y; Li Q; Li X; Feng X; Zeng K
Redox Biol; 2023 Nov; 67():102896. PubMed ID: 37783059
[TBL] [Abstract] [Full Text] [Related]
4. TMED2 Induces Cisplatin Resistance in breast cancer via Targeting the keap1-Nrf2 Pathway.
Liang C; Zhang HY; Wang YQ; Yang LA; Du YS; Luo Y; Zhang TC; Xu Y
Curr Med Sci; 2023 Oct; 43(5):1023-1032. PubMed ID: 37615927
[TBL] [Abstract] [Full Text] [Related]
5. PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating keap1 and inhibiting ferroptosis.
Wang Z; Li R; Hou N; Zhang J; Wang T; Fan P; Ji C; Zhang B; Liu L; Wang Y; Kong J; Yao Q; Duan J; Zhao G; Ling R; Zhang J
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37380368
[TBL] [Abstract] [Full Text] [Related]
6. Potential inhibitors of RPS6KB2 and NRF2 in head and neck squamous cell carcinoma.
Madhukar G; Subbarao N
J Biomol Struct Dyn; 2024; 42(4):1875-1900. PubMed ID: 37160694
[TBL] [Abstract] [Full Text] [Related]
7. Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state.
Yu W; Chen Y; Putluri N; Osman A; Coarfa C; Putluri V; Kamal AHM; Asmussen JK; Katsonis P; Myers JN; Lai SY; Lu W; Stephan CC; Powell RT; Johnson FM; Skinner HD; Kazi J; Ahmed KM; Hu L; Threet A; Meyer MD; Bankson JA; Wang T; Davis J; Parker KR; Harris MA; Baek ML; Echeverria GV; Qi X; Wang J; Frederick AI; Walsh AJ; Lichtarge O; Frederick MJ; Sandulache VC
Br J Cancer; 2023 Jun; 128(11):2013-2024. PubMed ID: 37012319
[TBL] [Abstract] [Full Text] [Related]
8. Availability of aldo-keto reductase 1C3 and ATP-binding cassette B1 as therapeutic targets for alleviating paclitaxel resistance in breast cancer MCF7 cells.
Matsunaga T; Horinouchi M; Saito H; Hisamatsu A; Iguchi K; Yoshino Y; Endo S; Ikari A
J Biochem; 2023 Mar; 173(3):167-175. PubMed ID: 36413758
[TBL] [Abstract] [Full Text] [Related]
9. LC-MS characterized methanolic extract of zanthoxylum armatum possess anti-breast cancer activity through Nrf2-keap1 pathway: An in-silico, in-vitro and in-vivo evaluation.
Sahu R; Kar RK; Sunita P; Bose P; Kumari P; Bharti S; Srivastava S; Pattanayak SP
J Ethnopharmacol; 2021 Apr; 269():113758. PubMed ID: 33359860
[TBL] [Abstract] [Full Text] [Related]
10. Antiproliferative Activity of Ursolic Acid in MDA-MB-231 Human breast cancer Cells through Nrf2 Pathway Regulation.
Zhang X; Li T; Gong ES; Liu RH
J Agric Food Chem; 2020 Jul; 68(28):7404-7415. PubMed ID: 32551573
[TBL] [Abstract] [Full Text] [Related]
11. Nrf2 promotes breast cancer cell migration via up-regulation of G6PD/HIF-1α/Notch1 axis.
Zhang HS; Zhang ZG; Du GY; Sun HL; Liu HY; Zhou Z; Gou XM; Wu XH; Yu XY; Huang YH
J Cell Mol Med; 2019 May; 23(5):3451-3463. PubMed ID: 30809937
[TBL] [Abstract] [Full Text] [Related]
12. NRF2 Induction Supporting breast cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-keap1 Interaction.
Lu K; Alcivar AL; Ma J; Foo TK; Zywea S; Mahdi A; Huo Y; Kensler TW; Gatza ML; Xia B
Cancer Res; 2017 Jun; 77(11):2881-2892. PubMed ID: 28416489
[TBL] [Abstract] [Full Text] [Related]
13. Expression and clinical significance of Kelch-like epichlorohydrin-associated protein 1 in breast cancer.
Zhang L; Yang WP; Wu LY; Zhu X; Wei CY
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323010
[TBL] [Abstract] [Full Text] [Related]
14. TrkB Promotes breast cancer Metastasis via Suppression of Runx3 and keap1 Expression.
Kim MS; Lee WS; Jin W
Mol Cells; 2016 Mar; 39(3):258-65. PubMed ID: 26657794
[TBL] [Abstract] [Full Text] [Related]
15. Monitoring the Antioxidant Mediated Chemosensitization and ARE-Signaling in Triple Negative breast cancer Therapy.
Foygel K; Sekar TV; Paulmurugan R
PLoS One; 2015; 10(11):e0141913. PubMed ID: 26536456
[TBL] [Abstract] [Full Text] [Related]
16. NRF2/miR-140 signaling confers radioprotection to human lung fibroblasts.
Duru N; Gernapudi R; Zhang Y; Yao Y; Lo PK; Wolfson B; Zhou Q
Cancer Lett; 2015 Dec; 369(1):184-91. PubMed ID: 26300493
[TBL] [Abstract] [Full Text] [Related]
17. Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in cancer.
Wijdeven RH; Pang B; van der Zanden SY; Qiao X; Blomen V; Hoogstraat M; Lips EH; Janssen L; Wessels L; Brummelkamp TR; Neefjes J
Cancer Res; 2015 Oct; 75(19):4176-87. PubMed ID: 26260527
[TBL] [Abstract] [Full Text] [Related]
18. Aromatase Inhibitor-Mediated Downregulation of inrf2 (keap1) Leads to Increased Nrf2 and Resistance in breast cancer.
Khatri R; Shah P; Guha R; Rassool FV; Tomkinson AE; Brodie A; Jaiswal AK
Mol Cancer Ther; 2015 Jul; 14(7):1728-37. PubMed ID: 25976679
[TBL] [Abstract] [Full Text] [Related]
19. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract] [Full Text] [Related]
20. keap1 Genetic Polymorphisms Associate with breast cancer Risk and Survival Outcomes.
Hartikainen JM; Tengström M; Winqvist R; Jukkola-Vuorinen A; Pylkäs K; Kosma VM; Soini Y; Mannermaa A
Clin Cancer Res; 2015 Apr; 21(7):1591-601. PubMed ID: 25589623
[TBL] [Abstract] [Full Text] [Related]
[Next]
